Hyaluronic Acid Viscosupplementation | Market Insights | Global | 2021
Overall, the HA viscosupplementation market will negatively impacted by the COVID-19 pandemic due to the elective and less urgent nature of these procedures. Once the market stabilizes, the global market for HA viscosupplementation will exhibit modest growth through 2029. While premium-priced 1-injection products will continue to become more popular over the forecast period, 3- and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the US, Europe, Asia Pacific, and Brazil across a 10-year period.
